289 related articles for article (PubMed ID: 10568763)
1. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
Hemauer A; Gigler A; Searle K; Beckenlehner K; Raab U; Broliden K; Wolf H; Enders G; Modrow S
J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses in parvovirus B19 infected patients.
Modrow S; Dorsch S
Pathol Biol (Paris); 2002 Jun; 50(5):326-31. PubMed ID: 12116851
[TBL] [Abstract][Full Text] [Related]
3. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.
Lehmann HW; Kühner L; Beckenlehner K; Müller-Godeffroy E; Heide KG; Küster RM; Modrow S
J Clin Virol; 2002 Aug; 25(2):135-43. PubMed ID: 12367647
[TBL] [Abstract][Full Text] [Related]
4. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen.
Venturoli S; Gallinella G; Manaresi E; Gentilomi G; Musiani M; Zerbini M
J Infect Dis; 1998 Dec; 178(6):1826-9. PubMed ID: 9815244
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
6. Long term follow up of serostatus after maternofetal parvovirus B19 infection.
Dembinski J; Eis-Hübinger AM; Maar J; Schild R; Bartmann P
Arch Dis Child; 2003 Mar; 88(3):219-21. PubMed ID: 12598382
[TBL] [Abstract][Full Text] [Related]
7. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
Heegaard ED; Rasksen CJ; Christensen J
J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
Jones LP; Erdman DD; Anderson LJ
J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
10. Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: implications for pathogenesis doubtful.
Searle K; Schalasta G; Enders G
J Med Virol; 1998 Nov; 56(3):192-8. PubMed ID: 9783684
[TBL] [Abstract][Full Text] [Related]
11. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
[TBL] [Abstract][Full Text] [Related]
12. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait.
Maksheed M; Pacsa AS; Essa SS; Ahmed MA; Monem RA; Surkouh M
Acta Trop; 1999 Oct; 73(3):225-9. PubMed ID: 10546839
[TBL] [Abstract][Full Text] [Related]
14. Human parvovirus B19 antibodies induce altered membrane protein expression and apoptosis of BeWo trophoblasts.
Tzang BS; Chiang SY; Chan HC; Liu CH; Hsu TC
Mol Med Rep; 2016 Nov; 14(5):4399-4406. PubMed ID: 27748859
[TBL] [Abstract][Full Text] [Related]
15. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
Kerr S; O'Keeffe G; Kilty C; Doyle S
J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
Heinz C; Plentz A; Bauer D; Heiligenhaus A; Modrow S
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):999-1004. PubMed ID: 15906067
[TBL] [Abstract][Full Text] [Related]
17. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
Tzang BS; Tsai CC; Tsay GJ; Wang M; Sun YS; Hsu TC
Clin Chim Acta; 2009 Jul; 405(1-2):76-82. PubMed ID: 19362081
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.
Elnifro E; Nisha AK; Almabsoot M; Daeki A; Mujber N; Muscat J
J Infect Dev Ctries; 2009 Apr; 3(3):218-20. PubMed ID: 19759477
[TBL] [Abstract][Full Text] [Related]
19. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?
Mitchell LA
J Med Virol; 2002 Jun; 67(2):267-74. PubMed ID: 11992589
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria.
Emiasegen SE; Nimzing L; Adoga MP; Ohagenyi AY; Lekan R
Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):227-31. PubMed ID: 21537685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
